Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference55 articles.
1. T-cell-receptor gene therapy;Schumacher;Nat Rev Immunol,2002
2. Adoptive cancer immunotherapy using genetically engineered designer T-cells: first steps into the clinic;Eshhar;Curr Opin Mol Ther,2010
3. Preclinical development of T cell receptor gene therapy;Bendle;Curr Opin Immunol,2009
4. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection;Kaech;Immunity,2007
5. Transcription factor regulation of CD8+ T-cell memory and exhaustion;Angelosanto;Immunol Rev,2010
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines;Journal of Peptide Science;2024-04-03
2. Expamers: a new technology to control T cell activation;Scientific Reports;2020-10-20
3. Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer;British Journal of Cancer;2019-02-12
4. CAR T Cells: Precision Cancer Immunotherapy;The Indonesian Biomedical Journal;2018-12-28
5. Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy;British Journal of Haematology;2018-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3